Recent Articles from StockStory
StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.
Website: https://www.stockstory.org
Shares of fresh produce company Dole (NYSE:DOLE)
fell 8.7% in the afternoon session after the company reported underwhelming first quarter 2025 results. Its EPS missed significantly, and its full-year EBITDA guidance fell slightly short of Wall Street's estimates. The shortfall came as adjusted EPS sank, hit by higher fruit costs, costly shipping delays, and the sale of its Progressive Produce business. Still, Dole beat revenue forecasts, with sales rising 4% on a like-for-like basis thanks to strong demand for bananas and better pricing for pineapples. Overall, this was a weaker quarter given the disappointing profit guidance.
Via StockStory · May 12, 2025
Shares of advertising software maker The Trade Desk (NASDAQ:TTD)
jumped 11.3% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of online study and academic help platform Chegg (NYSE:CHGG) jumped 5.1% in the afternoon session after the company reported decent first quarter 2025 results, which blew past analysts' EBITDA expectations, aided by aggressive cost-cutting from the previous year's restructuring plans. In addition, its revenue outperformed Wall Street's estimates. Yet, sales shrank 30%, and subscriber numbers plunged 31%, making it clear that fewer students are turning to the platform.
Via StockStory · May 12, 2025
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE)
fell 14.3% in the afternoon session after the company reported first quarter 2025 earnings as the news of the CEO stepping down dominated, casting a shadow over the otherwise decent results. The company announced that Lead Independent Director, Peter M. Neupert, will serve as Interim Chief Executive Officer and Board Chair, as Thomas Pike stepped down from his role beginning May 13, 2025. This likely created some uncertainty regarding the near-term direction of the business, which investors typically react negatively to. Also, sales slipped a bit compared to the previous year. Still, Fortrea blew past analysts' sales and earnings forecasts. Zooming out, we think this quarter featured some important positives marred by the uncertainty of leadership.
Via StockStory · May 12, 2025
Shares of server solutions provider Super Micro (NASDAQ:SMCI) jumped 6.1% in the morning session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of internet security and content delivery network Cloudflare (NYSE:NET)
jumped 7% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of cable news and media network Fox (NASDAQ:FOXA)
jumped 5.1% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' revenue, EPS, and EBITDA expectations. The outperformance came from a potent mix of sports and streaming, with the Super Bowl and Tubi's ad sales driving a 27% increase in sales. Zooming out, we think this quarter featured some important positives.
Via StockStory · May 12, 2025
Shares of athletic apparel brand Nike (NYSE:NKE)
jumped 6.9% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of iPhone and iPad maker Apple (NASDAQ:AAPL) jumped 5.1% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of beauty supply retailer Sally Beauty (NYSE:SBH) jumped 21.3% in the afternoon session after the company reported impressive first quarter 2025 results, with a significant margin improvement contributing to the EBITDA and EPS beat. On the other hand, sales fell 2.8%, weighed down by softer foot traffic and weaker demand for stylists due to the harsh flu season and macro uncertainty. Zooming out, we think this was a mixed yet decent marred by short-term challenges.
Via StockStory · May 12, 2025
Shares of cloud computing and online retail behemoth Amazon (NASDAQ:AMZN)
jumped 7.4% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Shares of social network operator Meta Platforms (NASDAQ:META)
jumped 6.6% in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
Via StockStory · May 12, 2025
Hospital management company Universal Health Services (NYSE:UHS) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 6.7% year on year to $4.1 billion. Its non-GAAP profit of $4.84 per share was 11.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Industrial conglomerate Crane (NYSE:CR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.3% year on year to $557.6 million. Its non-GAAP profit of $1.39 per share was 6.9% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Building products manufacturer Simpson (NYSE:SSD) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 1.6% year on year to $538.9 million. Its non-GAAP profit of $1.86 per share was 20.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Manufacturing company Leggett & Platt (NYSE:LEG) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.8% year on year to $1.02 billion. On the other hand, the company’s full-year revenue guidance of $4.15 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.24 per share was 9.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Chip manufacturer NXP Semiconductors (NASDAQ: NXPI) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 9.3% year on year to $2.84 billion. The company expects next quarter’s revenue to be around $2.9 billion, close to analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Network application delivery and security specialist F5 (NASDAQ:FFIV) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $731.1 million. The company expects next quarter’s revenue to be around $750 million, close to analysts’ estimates. Its non-GAAP profit of $3.42 per share was 10.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Wellness company Medifast (NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.2% year on year to $1.32 billion. The company expects next quarter’s revenue to be around $1.43 billion, close to analysts’ estimates. Its GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Metal packaging products manufacturer Crown Holdings (NYSE:CCK) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.7% year on year to $2.89 billion. Its non-GAAP profit of $1.67 per share was 35.4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Business automation software provider Upland Software (NASDAQ: UPLD) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 10% year on year to $63.66 million. On the other hand, next quarter’s revenue guidance of $53.3 million was less impressive, coming in 11.7% below analysts’ estimates. Its non-GAAP profit of $0.23 per share was 32.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.1% year on year to $1.24 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.19 billion at the midpoint. Its non-GAAP profit of $1.57 per share was 4.9% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Electronics manufacturing services company Sanmina (NASDAQ:SANM) announced better-than-expected revenue in Q1 CY2025, with sales up 8.1% year on year to $1.98 billion. On the other hand, next quarter’s revenue guidance of $1.98 billion was less impressive, coming in 5.5% below analysts’ estimates. Its non-GAAP profit of $1.41 per share was 2.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Aerospace and defense company Woodward (NASDAQ:WWD) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $883.6 million. The company’s full-year revenue guidance of $3.44 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $1.69 per share was 15.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Fast-food pizza chain Domino’s (NYSE:DPZ) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.5% year on year to $1.11 billion. Its non-GAAP profit of $4.33 per share was 6.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 6.4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Hospital operator HCA Healthcare (NYSE:HCA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.7% year on year to $18.32 billion. The company expects the full year’s revenue to be around $74.3 billion, close to analysts’ estimates. Its GAAP profit of $6.45 per share was 11.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Cable, internet, and telephone services provider Charter (NASDAQ:CHTR) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $13.74 billion. Its non-GAAP profit of $8.42 per share was 2% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Children’s apparel manufacturer Carter’s (NYSE:CRI) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.8% year on year to $629.8 million. Its non-GAAP profit of $0.66 per share was 27.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Health coverage company Centene (NYSE:CNC) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 15.4% year on year to $46.62 billion. The company’s full-year revenue guidance of $180 billion at the midpoint came in 4.2% above analysts’ estimates. Its non-GAAP profit of $2.90 per share was 15.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Electronic system and device provider Bel Fuse (NASDAQ:BELFA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 18.9% year on year to $152.2 million. Its GAAP profit of $1.36 per share was 64.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Health care services provider Encompass Health (NYSE:EHC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 10.6% year on year to $1.46 billion. The company’s full-year revenue guidance of $5.89 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.37 per share was 15% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Cable news and media network Fox (NASDAQ:FOXA) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 26.8% year on year to $4.37 billion. Its non-GAAP profit of $1.10 per share was 22.6% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Education company Lincoln Educational (NASDAQ:LINC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 13.7% year on year to $117.5 million. The company’s full-year revenue guidance of $490 million at the midpoint came in 1.2% above analysts’ estimates. Its GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Transportation and logistics solutions provider Universal Logistics (NASDAQ:ULH) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 22.3% year on year to $382.4 million. Its non-GAAP profit of $0.23 per share was 52.1% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Beer company Boston Beer (NYSE:SAM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 6.5% year on year to $453.9 million. Its GAAP profit of $2.17 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Waste management company Republic Services (NYSE:RSG) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3.8% year on year to $4.01 billion. Its non-GAAP profit of $1.58 per share was 3.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Online learning platform Coursera (NYSE:COUR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.1% year on year to $179.3 million. The company expects next quarter’s revenue to be around $181 million, close to analysts’ estimates. Its non-GAAP profit of $0.12 per share was 55.9% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
HVAC and electrical contractor Comfort Systems (NYSE:FIX) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.1% year on year to $1.83 billion. Its non-GAAP profit of $4.75 per share was 28.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Financial software provider SS&C Technologies (NASDAQ:SSNC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.4% year on year to $1.51 billion. The company expects next quarter’s revenue to be around $1.51 billion, close to analysts’ estimates. Its non-GAAP profit of $1.44 per share was 2.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Online study and academic help platform Chegg (NYSE:CHGG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 30.4% year on year to $121.4 million. On the other hand, next quarter’s revenue guidance of $101 million was less impressive, coming in 9.2% below analysts’ estimates. Its non-GAAP loss of $0.06 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.2% year on year to $776 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $3.38 billion at the midpoint. Its non-GAAP profit of $0.04 per share was $0.01 below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Electronic components manufacturer Knowles (NYSE:KN) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 32.7% year on year to $132.2 million. On top of that, next quarter’s revenue guidance ($140 million at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its non-GAAP profit of $0.18 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Medical device company Merit Medical Systems (NASDAQ:MMSI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 9.8% year on year to $355.4 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.86 per share was 14.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Gaming and hospitality company Boyd Gaming (NYSE:BYD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.2% year on year to $991.6 million. Its non-GAAP profit of $1.62 per share was 6.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Domain name registry operator Verisign (NASDAQ:VRSN) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.7% year on year to $402.3 million. Its GAAP profit of $2.10 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Footwear company Skechers (NYSE:SKX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $2.41 billion. Its non-GAAP profit of $1.34 per share was 13.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Project management software maker Monday.com (NASDAQ:MNDY) announced better-than-expected revenue in Q1 CY2025, with sales up 30.1% year on year to $282.3 million. The company expects next quarter’s revenue to be around $293 million, close to analysts’ estimates. Its non-GAAP profit of $1.10 per share was 56.4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance of $28.4 billion at the midpoint came in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.81 per share was 2.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Beauty supply retailer Sally Beauty (NYSE:SBH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 2.8% year on year to $883.1 million. On the other hand, the company expects next quarter’s revenue to be around $942.3 million, close to analysts’ estimates. Its non-GAAP profit of $0.42 per share was 6.6% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
3D measurement and imaging company FARO (NASDAQ:FARO) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $82.86 million. The company expects next quarter’s revenue to be around $83 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Medical technology company Integer Holdings (NYSE:ITGR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to $437.4 million. The company expects the full year’s revenue to be around $1.86 billion, close to analysts’ estimates. Its non-GAAP profit of $1.31 per share was 5.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Clinical research company Fortrea Holdings (NASDAQ:FTRE) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $651.3 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Aerospace and defense company Redwire (NYSE:RDW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 30.1% year on year to $61.4 million. On the other hand, the company’s full-year revenue guidance of $570 million at the midpoint came in 32.2% above analysts’ estimates. Its GAAP loss of $0.09 per share was 76.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Freight transportation company Union Pacific (NYSE:UNP) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.03 billion. Its non-GAAP profit of $2.70 per share was 1.1% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Vehicle manufacturer Shyft (NASDAQ:SHYF) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $204.6 million. The company’s full-year revenue guidance of $920 million at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Theme park operator United Parks & Resorts (NYSE:PRKS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.5% year on year to $286.9 million. Its GAAP loss of $0.29 per share was 26.7% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Business advisory firm FTI Consulting (NYSE:FCN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.3% year on year to $898.3 million. Its non-GAAP profit of $2.29 per share was 27.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Global airline American Airlines (NASDAQ:AAL) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $12.55 billion. Its non-GAAP loss of $0.59 per share was 12.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Commercial lighting and retail display solutions provider LSI (NASDAQ:LYTS) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.5% year on year to $132.5 million. Its non-GAAP profit of $0.20 per share was in line with analysts’ consensus estimates.
Via StockStory · May 12, 2025
Global advertising conglomerate Interpublic Group (NYSE:IPG) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 8.5% year on year to $2 billion. Its non-GAAP profit of $0.33 per share was 27.2% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Telecommunications and media company Comcast (NASDAQ:CMCSA) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $29.89 billion. Its non-GAAP profit of $1.09 per share was 10.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Fresh produce company Dole (NYSE:DOLE) announced better-than-expected revenue in Q1 CY2025, but sales fell by 1% year on year to $2.10 billion. Its non-GAAP profit of $0.35 per share was 10.7% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Consumer products behemoth Proctor & Gamble (NYSE:PG) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 2.1% year on year to $19.78 billion. Its non-GAAP profit of $1.54 per share was 0.9% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Beverage company Keurig Dr Pepper (NASDAQ:KDP) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 4.8% year on year to $3.64 billion. Its non-GAAP profit of $0.42 per share was 9.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Swimming pool distributor Pool (NASDAQ:POOL) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.4% year on year to $1.07 billion. Its GAAP profit of $1.42 per share was 4.1% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s full-year revenue guidance of $46.3 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.80 per share was 19.8% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Rural goods retailer Tractor Supply (NASDAQ:TSCO) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 2.1% year on year to $3.47 billion. The company’s full-year revenue guidance of $6 billion at the midpoint came in 61.8% below analysts’ estimates. Its GAAP profit of $0.34 per share was 9.1% below analysts’ consensus estimates.
Via StockStory · May 12, 2025
Security technology and services company ADT (NYSE:ADT) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 6.5% year on year to $1.27 billion. The company expects the full year’s revenue to be around $5.13 billion, close to analysts’ estimates. Its non-GAAP profit of $0.32 per share was 63.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Commercial real estate firm CBRE (NYSE:CBRE) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.3% year on year to $8.91 billion. Its non-GAAP profit of $0.86 per share was 12.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Boat and marine products retailer MarineMax (NYSE:HZO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.3% year on year to $631.5 million. Its non-GAAP profit of $0.23 per share was 19% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Manufacturing company Dover (NYSE:DOV) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $1.87 billion. Its non-GAAP profit of $2.05 per share was 3.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Aerospace and defense company Textron (NYSE:TXT) announced better-than-expected revenue in Q1 CY2025, with sales up 5.5% year on year to $3.31 billion. Its non-GAAP profit of $1.28 per share was 12.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025